[Recent advances in the clinical use of cytokines].
Kimura
Fumihiko
F
D000818:Animals; D002352:Carrier Proteins / Q000737:chemistry / Q000627:therapeutic use; D016207:Cytokines / Q000502:physiology; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000031:analogs & derivatives / Q000737:chemistry / Q000627:therapeutic use; D051523:Fibroblast Growth Factor 7 / Q000737:chemistry / Q000627:therapeutic use; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000737:chemistry / Q000627:therapeutic use; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D016298:Hematopoietic Cell Growth Factors / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D011092:Polyethylene Glycols; D011961:Receptors, Fc / Q000737:chemistry / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D013926:Thrombopoietin
D002352:Carrier Proteins; D016207:Cytokines; D016298:Hematopoietic Cell Growth Factors; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D004921:Erythropoietin; D051523:Fibroblast Growth Factor 7; D016179:Granulocyte Colony-Stimulating Factor; D000068256:Darbepoetin alfa; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D013926:Thrombopoietin; C488777:romiplostim; D000069585:Filgrastim